Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Gorana Matovina-Brko"'
Autor:
LAZAR S. POPOVIC, GORANA MATOVINA-BRKO, MAJA POPOVIC, KEVIN PUNIE, ANA CVETANOVIC, MATTEO LAMBERTINI
Publikováno v:
Oncology Research. 31:221-238
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07b008c7bc7fddd587d659f482115293
https://doi.org/10.32604/or.2023.028525
https://doi.org/10.32604/or.2023.028525
Publikováno v:
Handbook of Cancer and Immunology ISBN: 9783030809621
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4b4ead8232390aa6ce9e373a29e4927
https://doi.org/10.1007/978-3-030-80962-1_229-1
https://doi.org/10.1007/978-3-030-80962-1_229-1
Autor:
Gorana, Matovina Brko, Maja, Popovic, Masa, Jovic, Jelena, Radic, Milka, Bodlovic Kladar, Ivan, Nikolic, Vladimir, Vidovic, Ivana, Kolarov Bjelobrk, Biljana, Kukic, Svetlana, Salma, Jelena, Litavski, Nemanja, Petrovic, Bojana, Vranjkovic, Tatjana, Roganovic, Maja, Ruzic, Tihomir, Dugandzija, Lazar, Popovic
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(5)
Recommendations and guidelines consider cancer patients a high-priority population for COVID-19 immunization. Vaccination process in Serbia began in January 2021 with four available vaccines. We have conducted a cross-sectional study investigating ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e2b9787c120bbae6212fd97968ed690f
https://pubmed.ncbi.nlm.nih.gov/34761633
https://pubmed.ncbi.nlm.nih.gov/34761633
Publikováno v:
World Journal of Clinical Oncology
Renal cell cancer (RCC) represents 2%-3% of all adulthood cancers and is the most common malignant neoplasm of the kidney (90%). In the mid-nineties of the last century, the standard of treatment for patients with metastatic RCC was cytokines. Suniti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::240c184d50b68f0f780d419884b1ccab
https://pubmed.ncbi.nlm.nih.gov/35116230
https://pubmed.ncbi.nlm.nih.gov/35116230
Autor:
Dragana Petrovic, Maja Popović, Gorana Matovina-Brko, Ivan Nikolic, Milica Popovic, Biljana Kukic, Ana Cvetanovic, Lazar Popovic
Publikováno v:
World Journal of Stem Cells
Relapsed or refractory non-Hodgkin's lymphomas, especially diffuse large B-cell lymphoma as well as relapsed or refractory Hodgkin lymphomas are hard-to-treat diseases. Patients who do not respond to initial therapy or experience relapse are treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94bd755710346e33e412f19316472314
https://pubmed.ncbi.nlm.nih.gov/34249225
https://pubmed.ncbi.nlm.nih.gov/34249225
Autor:
Gorana Matovina-Brko, Bojana Vranjkovic, Jelena Radic, Dragana Petrovic, Maja Popović, Lazar Popovic
Publikováno v:
Medical review. 72:25-29
Introduction. The research aimed to evaluate the impact of age-adjusted international prognostic index and time to the first relapse on overall survival and progression-free survival from the beginning of the second line of treatment in patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a0273bea52bb13a7a827bd6db40107b
https://doi.org/10.2298/mpns1902025p
https://doi.org/10.2298/mpns1902025p
Autor:
Darjana Jovanovic, Gorana Matovina-Brko, Zoran Nikin, Svetlana Popovic-Petrovic, Borislava Nikolin, Lazar Popovic
Publikováno v:
Contemporary Oncology
Sarcomas represent large and diverse group of malignant tumours, originating from mesenchymal cells. Nearly 15% of all childhood tumours and about 1% of all tumours in adults are sarcomas [1]. The incidence of adult soft tissue sarcomas in Europe is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31c6622df746248e75097fcf7f06842d
https://doi.org/10.5114/wo.2015.52661
https://doi.org/10.5114/wo.2015.52661
Autor:
Maja Ruzic, Zoran Milosevic, Milotka Fabri, Tomislav Preveden, Gorana Matovina-Brko, Sanja Stojanovic
Publikováno v:
Medical review. 67:31-38
Introduction. The incidence of chronic hepatitis C and its consequences, liver cirrhosis and hepatocellular carcinoma is growing rapidly. The aim of this study was to evaluate clinical characteristics of patients with hepatocellular carcinoma and chr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1db67673c64d4c45a4ac620a629dfcb6
https://doi.org/10.2298/mpns14s2031r
https://doi.org/10.2298/mpns14s2031r
Autor:
Gorana Matovina-Brko, Milotka Fabri, Lazar Popovic, Danijela Petkovic, Jasna Trifunovic, Ivana Kolarov-Bjelobrk, Maja Ruzic
Publikováno v:
Journal of Chemotherapy. 26:180-183
Oncologists worldwide are often dealing with hepatitis C virus positive breast cancer patients, questioning adequate chemotherapy protocol, reduction of doses, delays, or even interruptions of treatment. We present a case of a woman in stage IIIB bre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbfa0ec5bfb8b1ee4c1354fc3d3e1fff
https://doi.org/10.1179/1973947813y.0000000129
https://doi.org/10.1179/1973947813y.0000000129
Autor:
Maja Ruzic, Gorana Matovina-Brko, Jasna Trifunovic, Ivana Kolarov-Bjelobrk, Milotka Fabri, Lazar Popovic
Publikováno v:
Archive of Oncology. 21:151-154
The natural course of hepatitis B virus (HBV) infection depends on the immune status of the host. In cancer patients, as the consequence of immune suppression due to chemotherapy and malignant disease itself, the balance between replicative potential
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05846f3fcba2ca52e4e8a675b24582d4
https://doi.org/10.2298/aoo1304151m
https://doi.org/10.2298/aoo1304151m